News & Updates

New drug applications approved by US FDA as of 16-31 May 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Children who attend childcare are at greater risk of adenovirus and human metapneumovirus infection, and they are also often exposed to other respiratory viruses in such environments, reveals a study.

Administration of maternal influenza vaccine during the first- or second-trimester of pregnancy reduces the risk of influenza-like illness (ILI) in the offspring, according to a study presented at ESPID 2023.

The presence of Pseudomonas aeruginosa worsens an already deficient airway secretory leukocyte protease inhibitor (SLPI), an antiprotease that helps prevent tissue damage, in patients with cystic fibrosis (CF), reports a study. Moreover, female patients show markedly lower SLPI levels than males.

Endobronchial valves (EBVs) treatment results in a decrease in dynamic hyperinflation (DH), as shown in a study, which notes the association of such improvement with static changes.